Device / Technology News

RSS

RCLCF launches interactive Lung Cancer Smart Map

Lung cancer patients can now check they are getting the best care available after the launch of a new interactive online map.

31 Jul 2013

Revolutionary new neck support collars for patients with Motor Neurone Disease

A revolutionary new device to replace ‘hated’ neck support collars for Motor Neurone Disease (MND) patients has been developed.

31 Jul 2013

Chemists develop new method for parallel protein analysis

Chemists at Johannes Gutenberg University Mainz (JGU) have developed a new method for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins. It could be used to detect the presence of viruses and identify their type in tiny samples. At the same time, it is very cost-effective and quick.

31 Jul 2013

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

Case Western Reserve University has granted a two-year technology transfer option to a research spinoff company developing a hand-held device that diagnoses malaria more quickly, simply and affordably than existing methods.

31 Jul 2013

SAM Junctional Tourniquet gets FDA clearance to control difficult bleeds in the axilla area

SAM Medical Products is pleased to announce it has received 510(k) regulatory clearance from the FDA to add an additional indication of use to the SAM Junctional Tourniquet.

31 Jul 2013

New needle-free treatment may dramatically reduce global snakebite fatalities

A team of researchers led by Dr. Matt Lewin of the California Academy of Sciences, in collaboration with the Department of Anesthesia at the University of California, San Francisco, has pioneered a novel approach to treating venomous snakebites-administering antiparalytics topically via a nasal spray.

31 Jul 2013

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians, new research has shown.

31 Jul 2013

Researchers create computational model to track VRE spread among hospitals

A moderate increase in vancomycin-resistant enterococci (VRE) at one hospital can lead to a nearly 3 percent increase in VRE in every other hospital in that county, according to a study in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

31 Jul 2013

OGT to release new CytoSure Consortium Cancer +SNP array for CNV and LOH detection

Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, will launch its new CytoSure™ Consortium Cancer +SNP array (4x180k) at the Cancer Cytogenomics Microarray Consortium (CCMC) and Cytogenomics Array Group (CAGdb) combined meeting in Chicago on the 5th- 7th August, booth 4.

From Oxford Gene Technology 30 Jul 2013

Adocia, Lilly terminate collaboration agreement relating to fast-acting insulin analog

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.

30 Jul 2013

New CardioChek Plus analyzer delivers rapid test results for lipids and glucose

Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, introduced the CardioChek Plus analyzer today at the annual American Association for Clinical Chemistry (AACC) in Houston.

30 Jul 2013

Affymetrix introduces cost-effective, high-throughput Axiom 384HT format for genotyping

Affymetrix, Inc. (NASDAQ: AFFX) announces the introduction of the Axiom® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for genotyping in which 384 samples are simultaneously processed with 384 discrete microarrays in a microplate format analyzing up to 50,000 SNPs per sample.

30 Jul 2013

Graduate student receives NIH fellowship of more than $90,000 to study e-cigarette use

Ever since e-cigarettes hit the market in 2004, they have been advertised as an aid for cigarette smoking cessation. The aerosols produced by e-cigarettes, however, have yet to be screened for potential health risks.

30 Jul 2013

Vanderbilt offers first FDA-approved bionic eye for treatment of retinitis pigmentosa

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).

30 Jul 2013

Study: Digital tomosynthesis reduces recall rate in breast cancer screening

Digital tomosynthesis is an effective tool for reducing the recall rate in breast cancer screening, according to a new study published online in the journal Radiology.

30 Jul 2013

NeuroSigma receives FDA approval to begin Phase III trial of Monarch eTNS System for epilepsy

NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration of its Investigational Device Exemption application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy.

30 Jul 2013

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.

29 Jul 2013

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body.

29 Jul 2013

Technique for developing more targeted drugs using molecular "robots"

Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more specific populations of cells.

29 Jul 2013

Leapfrog unveils new tool that allows purchasers to calculate money spent on medical errors

During a time of flux for U.S. health care, employers and purchasers are increasingly concerned about how much value they receive for their enormous investment in health care. In a presentation yesterday evening at the World Health Congress Innovative Drivers of Value Based Purchasing Seminar, Leah Binder, president and CEO of the employer-driven nonprofit The Leapfrog Group, unveiled a new tool that allows purchasers to calculate how much they spend annually on unnecessary costs due to medical errors that occur within general acute care hospitals.

26 Jul 2013

Device / Technology News

RCLCF launches interactive Lung Cancer Smart Map

Revolutionary new neck support collars for patients with Motor Neurone Disease

Chemists develop new method for parallel protein analysis

CWRU grants technology transfer option to Disease Diagnostic Group to evaluate RAM device

SAM Junctional Tourniquet gets FDA clearance to control difficult bleeds in the axilla area

New needle-free treatment may dramatically reduce global snakebite fatalities

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

Researchers create computational model to track VRE spread among hospitals

OGT to release new CytoSure Consortium Cancer +SNP array for CNV and LOH detection

Adocia, Lilly terminate collaboration agreement relating to fast-acting insulin analog

New CardioChek Plus analyzer delivers rapid test results for lipids and glucose

Affymetrix introduces cost-effective, high-throughput Axiom 384HT format for genotyping

Graduate student receives NIH fellowship of more than $90,000 to study e-cigarette use

Vanderbilt offers first FDA-approved bionic eye for treatment of retinitis pigmentosa

Study: Digital tomosynthesis reduces recall rate in breast cancer screening

NeuroSigma receives FDA approval to begin Phase III trial of Monarch eTNS System for epilepsy

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

Technique for developing more targeted drugs using molecular "robots"

Leapfrog unveils new tool that allows purchasers to calculate money spent on medical errors

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News